New Era of Preventing End-Stage Kidney Disease Act
Latest action · Feb 24, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedFeb 24, 2025
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
New Era of Preventing End-Stage Kidney Disease Act
This bill establishes regional centers of excellence, postgraduate fellowships, and training for health professionals relating to the diagnosis and treatment of rare kidney disease. It also requires the Department of Health and Human Services (HHS) to conduct various studies on rare kidney disease.
Specifically, it authorizes the National Institute of Diabetes and Digestive and Kidney Diseases to award funding to public and private nonprofit entities for establishing regional centers of excellence that will increase public awareness, conduct research, and develop resources for diagnosing and treating rare kidney diseases. A center may receive such funding for up to five years, unless extended by the institute.
The bill also requires health professions schools receiving a grant from the Health Resources and Services Administration (HRSA) Centers of Excellence program to award fellowships for training on preventing, diagnosing, and treating rare kidney disease in disproportionately impacted populations.
Also, the bill expands the priorities of HRSA’s Primary Care Training and Enhancement program to include training for health care workers to care for individuals with kidney disease.
Additionally, HHS must conduct several studies and report to Congress on topics such as treating rare kidney disease in disproportionately affected populations, eliminating the need for dialysis or kidney transplants, and increasing public awareness of rare kidney disease.
Cosponsors 64
Members who signed on, in the order they did. Signatures ran from Feb 24, 2025 to Oct 15, 2026; 7 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-IL | Bradley Scott Schneider | Original | Feb 24, 2025 |
| R-WV | Carol D. Miller | Original | Feb 24, 2025 |
| D-IL | Danny K. Davis | Original | Feb 24, 2025 |
| D-NY | Paul Tonko | Original | Feb 24, 2025 |
| D-CA | Scott H. Peters | Original | Feb 24, 2025 |
| D-AL | Terri A. Sewell | Original | Feb 24, 2025 |
| R-OH | Troy Balderson | Original | Feb 24, 2025 |
| D-CA | Ted Lieu | Mar 3, 2025 | |
| R-FL | Neal P. Dunn | Mar 10, 2025 | |
| R-PA | Brian K. Fitzpatrick | Mar 11, 2025 | |
| R-TX | Dan Crenshaw | Mar 14, 2025 | |
| D-DC | Eleanor Holmes Norton | May 7, 2025 | |
| D-NY | Thomas R. Suozzi | May 14, 2025 | |
| R-CA | Jay Obernolte | May 19, 2025 | |
| D-CA | Julia Brownley | May 19, 2025 | |
| R-NY | Michael Lawler | May 19, 2025 | |
| D-FL | Kathy Castor | Jun 3, 2025 | |
| D-NC | Donald G. Davis | Jun 6, 2025 | |
| R-SC | Joe Wilson | Jun 23, 2025 | |
| D-MI | Rashida Tlaib | Jun 30, 2025 | |
| D-GA | Henry C. "Hank" Johnson, Jr. | Jul 23, 2025 | |
| D-NY | Patrick Ryan | Jul 23, 2025 | |
| R-NY | Andrew R. Garbarino | Jul 25, 2025 | |
| D-NY | Jerrold Nadler | Jul 25, 2025 | |
| D-GA | Sanford D. Bishop, Jr. | Jul 25, 2025 | |
| D-CA | J. Luis Correa | Jul 29, 2025 | |
| D-MA | James P. McGovern | Jul 29, 2025 | |
| D-IL | Jonathan L. Jackson | Aug 1, 2025 | |
| D-CO | Jason Crow | Aug 5, 2025 | |
| D-TX | Al Green | Aug 12, 2025 | |
| D-FL | Darren Soto | Aug 12, 2025 | |
| D-NC | Deborah K. Ross | Aug 12, 2025 | |
| D-CA | Zoe Lofgren | Aug 12, 2025 | |
| D-NJ | Robert Menendez | Aug 19, 2025 | |
| D-DE | Sarah McBride | Aug 26, 2025 | |
| D-NY | Alexandria Ocasio-Cortez | Sep 3, 2025 | |
| D-VA | Eugene Simon Vindman | Sep 3, 2025 | |
| R-CA | Young Kim | Sep 3, 2025 | |
| D-MD | Glenn Ivey | Sep 30, 2025 | |
| D-NJ | Jefferson Van Drew | Sep 30, 2025 | |
| D-MI | Haley M. Stevens | Oct 21, 2025 | |
| R-OH | Mike Carey | Oct 21, 2025 | |
| D-TX | Henry Cuellar | Nov 4, 2025 | |
| R-NE | Mike Flood | Nov 4, 2025 | |
| D-NM | Gabe Vasquez | Dec 17, 2025 | |
| R-VA | Jennifer A. Kiggans | Feb 26, 2026 | |
| D-NV | Susie Lee | Feb 26, 2026 | |
| D-MS | Bennie G. Thompson | Apr 6, 2026 | |
| D-OR | Janelle S. Bynum | Apr 6, 2026 | |
| D-CA | Judy Chu | Apr 6, 2026 | |
| D-WI | Mark Pocan | Apr 6, 2026 | |
| D-CA | Mike Levin | Apr 6, 2026 | |
| D-TX | Veronica Escobar | Apr 6, 2026 | |
| D-NY | Yvette D. Clarke | Apr 6, 2026 | |
| D-CA | Mike Thompson | Apr 20, 2026 | |
| D-VA | James R. Walkinshaw | Apr 22, 2026 | |
| R-AZ | Abraham J. Hamadeh | Jul 27, 2026 | |
| R-MI | Jack Bergman | Jul 27, 2026 | |
| D-MA | William R. Keating | Aug 13, 2026 | |
| R-TN | Charles J. "Chuck" Fleischmann | Aug 20, 2026 | |
| R-NE | Don Bacon | Aug 20, 2026 | |
| D-WI | Gwen Moore | Oct 5, 2026 | |
| D-ME | Chellie Pingree | Oct 9, 2026 | |
| R-NJ | Christopher H. Smith | Oct 15, 2026 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Feb 24, 2025 |
| House | Ways and Means Committee | Referred Feb 24, 2025 |
Actions 2
Everything that happened, newest first.
- Feb 24, 2025Introduced in House
- Feb 24, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 171, no. 36, February 24, 2025, page H769.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 9877 | Health Equity and Accountability Act of 2026 | Related bill | Sep 29, 2026 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Public Health Service Act with respect to preventing end-stage kidney disease, and for other purposes.
- Short Title(s) as Introduced
- New Era of Preventing End-Stage Kidney Disease Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Congressional oversight
- Digestive and metabolic diseases
- Genetics
- Government studies and investigations
- Health
- Health care coverage and access
- Health programs administration and funding
- Health promotion and preventive care
- Medical education
- Medical research
- Medical tests and diagnostic methods
- Research administration and funding
Text 1
Each version as it was printed, newest first.
- Feb 24, 2025Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
